Theratechnologies Inc. reaffirming earnings guidance for the fiscal year 2024. For the year, the company expects revenue guidance range is confirmed between $87 million and $90 million as compared to the 2023 fiscal year results.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 CAD | -0.56% | -3.24% | -16.36% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.36% | 60.29M | |
-3.45% | 87.17B | |
+1.97% | 40.1B | |
+58.05% | 25.12B | |
-14.82% | 15.59B | |
-8.82% | 12B | |
-16.29% | 11.8B | |
-41.58% | 11.8B | |
+7.49% | 8.81B | |
-10.18% | 8.24B |
- Stock Market
- Equities
- TH Stock
- News Theratechnologies Inc.
- Theratechnologies Inc. Re-Affirms Earnings Guidance for the Fiscal Year 2024